| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TEREX CORP | Director | Common Stock, par value $.01 | 32.1K | $1.84M | $57.46 | Nov 4, 2022 | Direct |
| Lexeo Therapeutics, Inc. | Director | Common Stock | 30.6K | $214K | $6.99 | Nov 25, 2024 | Direct |
| Lexeo Therapeutics, Inc. | Director | Stock Option (right to buy) | 25K | Jun 26, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | Jun 26, 2025 | 1 | $0 | 4 | Jun 30, 2025 | Director |
| LXEO | Lexeo Therapeutics, Inc. | Nov 25, 2024 | 1 | $105K | 4 | Nov 26, 2024 | Director |
| LXEO | Lexeo Therapeutics, Inc. | Jun 25, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
| LXEO | Lexeo Therapeutics, Inc. | Nov 2, 2023 | 0 | $0 | 3 | Nov 2, 2023 | Director |
| TEX | TEREX CORP | Nov 4, 2022 | 1 | -$824K | 4 | Nov 8, 2022 | Director |